...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Name Confusion

Yes , I believe that is correct , just looking for Zenith to get it right & get out there along with what the current value actually is. Makes me frustrated that the TD & others can't get it right! Sarah said their looking into it, well how long can that take in today's age??? Think it would be cleared up in day , not weeks or months .....

Share
New Message
Please login to post a reply